Recent advances in technology, genetics, and translational research are facilitating the discovery of new risk genes, disease pathways, and potential therapies. Modern tools such as gene editing, spatial transcriptomics, single molecule fluorescence, viral vector engineering, and organoid development have contributed to uncovering the importance of immune mechanisms, RNA metabolism, and lysosomal biology in neurodegenerative diseases.
The Keystone Symposia Conference on Neurodegenerative Diseases will gather leaders in basic, clinical, and translational research to discuss their latest findings and innovative ideas in these areas. It will also showcase new models, tools, and technologies that enhance our understanding of neurodegenerative diseases. Additionally, by aligning this conference with the Neuroimmune Interactions event, it aims to foster interdisciplinary collaboration in identifying immune-related issues and therapeutic targets for various neurodegenerative disorders, where promising treatments are emerging.
The 2024 Keystone Symposia Conference on Neurodegenerative Diseases will take place June 3-6 at the Santa Fe Community Center, New Mexico, United States.
To learn more visit the Keystone Symposia Conference on Neurodegenerative Diseases website.
.png)
